China -based Sinovac Biotech Ltd said a late-stage trial of its experimental vaccine for hand, foot and mouth disease met the main study goal of preventing the infection in infants between the ages of 6 months and 35 months.
via Darien Newswire http://www.courant.com/health/sns-rt-us-sinovac-study-vaccinebre92d0hf-20130314,0,1999359.story
via Darien Newswire http://www.courant.com/health/sns-rt-us-sinovac-study-vaccinebre92d0hf-20130314,0,1999359.story
No comments:
Post a Comment